Agilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Business Wire
Expanded PD-L1 indication and end-to-end digital pathology workflows support modern pathology practice SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas. Agilent will highlight expanded biomarker testing capabilities, continued progress in digital pathology adoption, and the evolving role of the Dako Omnis family of instruments as a foundation for scalable, automation-ready pathology laboratories.At USCAP 2026, Agilent will feature its continued expansion in oncology diagnostics, including a new PD-L1 indication for epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (EOC), reinforcing Agilent’s commitment to supporting biomarker-driven precision oncology. This addition builds on Agilent’s established PD-L1 po
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Assessing Agilent Technologies (A) Valuation After Recent Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Emerald Growth Equity Strategy Sold Agilent (A) Due to Compression in the Margin of Safety [Yahoo! Finance]Yahoo! Finance
- Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States [Yahoo! Finance]Yahoo! Finance
- Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United StatesBusiness Wire
- Jim Cramer on Agilent Technologies: “I Don't Think You Need It” [Yahoo! Finance]Yahoo! Finance
A
Earnings
- 2/25/26 - Miss
A
Sec Filings
- 3/20/26 - Form 8-K
- 3/6/26 - Form 8-K
- 3/3/26 - Form 10-Q
- A's page on the SEC website